Literature DB >> 18459053

Determination of reference ultrasound parameters for model and hydrofluoroalkane propellants using high-resolution ultrasonic spectroscopy.

Susan Hoe1, Paul M Young, Philippe Rogueda, Daniela Traini.   

Abstract

The aim of this research was to determine the reference ultrasonic velocity (v) and attenuation coefficient (alpha) for 2H, 3H-perfluoropentane (HPFP), 1,1,1,2-tetrafluoroethane (HFA-134a) and 1,1,1,2,3,3,3-tetrafluoroethane (HFA-227) propellants, for the future purpose of characterising pressurised metered dose inhaler (pMDI) formulations using high-resolution ultrasonic spectroscopy (HRUS). Perfluoroheptane (PFH) was used as a reference material for HPFP. With its velocity and attenuation coefficient determined at 25 degrees C, HPFP was subsequently used as a reference for HFA-134a and HFA-227. It was found that there is a linear decline in ultrasonic velocity with an increase in temperature. As with HPFP, the ultrasonic velocity of HFA-134a and HFA-227 were successfully calculated at 25 degrees C. However, the difference in density and viscosity between reference and sample prevented accurate determination of reference attenuation coefficient for the hydrofluoroalkanes. With ultrasonic velocity alone, dispersion concentration and stability monitoring for experimental pMDI formulations is possible using HRUS. However, at this point in time measurement of particle size is not feasible.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18459053      PMCID: PMC2976968          DOI: 10.1208/s12249-008-9087-z

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  12 in total

1.  Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor.

Authors:  W T Kwong; S L Ho; A L Coates
Journal:  J Aerosol Med       Date:  2000

2.  Application of co-grinding to formulate a model pMDI suspension.

Authors:  R O Williams; M A Repka; M K Barron
Journal:  Eur J Pharm Biopharm       Date:  1999-09       Impact factor: 5.571

3.  HPFP, a model propellant for pMDIs.

Authors:  Philippe G A Rogueda
Journal:  Drug Dev Ind Pharm       Date:  2003-01       Impact factor: 3.225

4.  Determination of the heat stability profiles of concentrated milk and milk ingredients using high resolution ultrasonic spectroscopy.

Authors:  L Lehmann; V Buckin
Journal:  J Dairy Sci       Date:  2005-09       Impact factor: 4.034

5.  The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability.

Authors:  A Brindley
Journal:  J Allergy Clin Immunol       Date:  1999-12       Impact factor: 10.793

6.  Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system.

Authors:  Y Michael; M J Snowden; B Z Chowdhry; I C Ashurst; C J Davies-Cutting; T Riley
Journal:  Int J Pharm       Date:  2001-06-19       Impact factor: 5.875

7.  Study of emulsion stabilization by graft copolymers using the optical analyzer Turbiscan.

Authors:  Caroline Lemarchand; Patrick Couvreur; Christine Vauthier; Dominique Costantini; Ruxandra Gref
Journal:  Int J Pharm       Date:  2003-03-18       Impact factor: 5.875

8.  High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.

Authors:  S A Jones; G P Martin; M B Brown
Journal:  Int J Pharm       Date:  2005-09-30       Impact factor: 5.875

9.  Investigation of the molecular interactions in a pMDI formulation by atomic force microscopy.

Authors:  Roya Ashayer; Paul F Luckham; Sivasegaram Manimaaran; Philippe Rogueda
Journal:  Eur J Pharm Sci       Date:  2004-03       Impact factor: 4.384

10.  Manipulation of beclomethasone-hydrofluoroalkane interactions using biocompatible macromolecules.

Authors:  Stuart A Jones; Gary P Martin; Marc B Brown
Journal:  J Pharm Sci       Date:  2006-05       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.